Anders Grøn

Clinical Microbiomics new CEO, Anders Grøn, who will take the lead October 1st, 2021. Anders replaces Martin Santini, who has successfully led Clinical Microbiomics since 2016, and who has now chosen to look for new challenges. Anders Grøn comes from a position as Group Vice President of IFF (prev. Dupont), and global leader for IFF Health, including the activities within probiotics, Human Milk Oligosaccharides and other microbiome focused solutions.

Before that Anders held leading positions at Coloplast and Chr. Hansen. Anders Grøn will be leading the continued development of Clinical Microbiomics, focusing on global expansion and scientific leadership within the microbiome field.